Skip to content
Unrated Drug recall · FDA · Published October 15, 2025

ProRx Semaglutide Injection Recall: Risk of Contamination

ProRx recalls Semaglutide injections with potential contamination risk. Affected lots have specific batch numbers and expiration dates. Consumers should contact ProRx for details.

🇺🇸 FDA recall #D-0115-2026DrugProRx ›
Take action

Contact the company

Recalling firmProRx LLC619 Jeffers Cir · Exton, PA 19341-2540
✎ GovInfoNow plain-language explainer

What happened, in plain English

ProRx is recalling certain Semaglutide injections due to a lack of assurance of sterility. This means the product could be contaminated, posing a risk of infection after injection. Read more at govinfonow.com/recall/31693-prorx-semaglutide-injection-recall-risk-of-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/31693-prorx-semaglutide-injection-recall-risk-of-contamination · Updated August 18, 2026 · FDA enforcement record: FDA #D-0115-2026

Cite this page

“ProRx Semaglutide Injection Recall: Risk of Contamination.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31693-prorx-semaglutide-injection-recall-risk-of-contamination. Based on FDA recall #D-0115-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0115-2026%22&limit=1).

Why it’s dangerous

The product lacks assurance of sterility, meaning it could be contaminated with bacteria or other pathogens. If injected, this could lead to infections or other health issues.

Who’s affected

People who have been prescribed Semaglutide injections by a doctor and received the recalled lots. Those with the specific batch numbers listed are most at risk.

How to tell if you have this one

Check the product label for the batch numbers: PRORX050925-1, PRORX051425-5, or PRORX051425-6. The expiration date (BUD) for these lots is November 4, 2025 or November 10, 2025.

  • Brand
    ProRx
  • Category
    Drug
FDA recall event · 7 products

All 7 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    TX and UT
Recall numberProduct, codes & lotsQuantity
D-0114-2026Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09; Lot# Prorx04282025-32,809 vials
D-0115-2026Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-04; Lot, Best Use Date (BUD): Lot PRORX050925-1, BUD November 4, 2025; Lot ProRx051425-5, BUD November 10, 2025; Lot ProRx051425-6, BUD November 10, 20258,400 vials
D-0116-2026Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08; Lot Prorx051425-2, Lot Prorx051425-3 and Lot Prorx051425-48,310 vials
D-0117-2026Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09; Lot Prorx051525-1, Prorx051525-2, Prorx051525-3 and Prorx051525-411,119 vials
D-0118-2026Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-06; Lot Prorx051525-52,649 vials
D-0119-2026Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02; Lot PRORX052125-42,805 vials
D-0120-2026Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03; Lot PRORX08062025-32,761 vials
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the batch numbers: PRORX050925-1, PRORX051425-5, or PRORX051425-6 on the vial.

Where it went and when

Where it was distributed

Distributed in Texas and Utah.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: yesUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “TX and UT” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas, Utah.

Recall timeline

FDA published this recall 21 days after the firm started it.

1. Firm started the recall: Oct 15, 202512. FDA classified it Class II: Oct 27, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0115-2026 (October 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0115-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA